The mortality risk of patients hospitalized for ischemic stroke between 2003 and 2019
Authors:
Lenka Kielbergerová 1; Otto Mayer Jr. 1,2; Jan Bruthans 1,3
Authors‘ workplace:
Neurochirurgická klinika, Fakultní nemocnice, Plzeň
1; II. interní klinika, Univerzita Karlova, Lékařská fakulta a Fakultní nemocnice, Plzeň
2; Biomedicínské centrum, Univerzita Karlova, Lékařská fakulta a Fakultní nemocnice, Plzeň
3; Centrum kardiovaskulární prevence, Thomayerova nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha
4
Published in:
Vnitř Lék 2022; 68(E-3): 4-11
Category:
Original Contributions
Overview
Background: Stroke represents an essential part of the burden of cardiovascular diseases. Despite specific mortality from cerebrovascular diseases decreasing in the Czech Republic since the ‘80s, the trends in case fatality and individual risk of patients who suffered from stroke remain questionable. In patients hospitalized for ischemic stroke, we evaluated the mortality trends in the last two decades.
Methods: 9076 patients (mean age 71.8, 51.9% males) hospitalized for ischemic stroke between 2003 and 2019 were followed. The vital status we ascertained up to 31.12.2020, other circumstances from the hospital information system
Results: In total, 5583 patients died during follow-up. The in-hospital fatality was 9.1%, 30-day mortality 14.2%, and 1-year mortality 28.4%. In patients hospitalized from 2003 to 2015, the 5-year mortality was 49.8%. No significant changes were noted for in-hospital fatality, 30-days, 1-year mortality, as well as 5-years mortality risk across more extensive periods (2003-07, 2008-11, 2012-15 and 2016-19). As expected, any decade of patient´s age was associated with about two-fold higher mortality risk. Intravenous thrombolysis, as part of initial management, markedly increased over time (from 2.4% in 2003-07 to 48.1% in 2016-19). However, this procedure affected beneficially only 1-year mortality risk, while regarding 5-years mortality was its effect neutral.
Conclusions: Despite favorable trends in cerebrovascular events from a population perspective, the individual prognosis of patients who have suffered a stroke remains very poor.
Keywords:
Prognosis – mortality – cerebrovascular accidents – in‑hospital fatality
Sources
1. Bruthans J, Cifkova R, Lanska V, O‘Flaherty M, Critchley JA, Holub J et al. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007. Eur J Prev Cardiol. 2014;21:829-39.
2. ÚZIS. Zdravotnická statistika. Zemřelí 2017. stav zdravotnických informací a statistiky ČR. 2018. Praha. dostupné z https://www.uzis.cz/sites/default/files/knihovna/demozem2017. pdf. 2018.
3. Heuschmann PU, Kircher J, Nowe T, Dittrich R, Reiner Z, Cifkova R et al. Control of main risk factors after ischaemic stroke across Europe: data from the stroke‑specific module of the EUROASPIRE III survey. Eur J Prev Cardiol. 2015;22:1354-62.
4. Cífková R, Wohlfahrt P, Krajčoviechová A, Jozífová M, Mayer O, Vaněk J et al. Blood pressure control and risk profile in poststroke survivors: a comparison with the general population. J Hypertens. 2015;33:2107-14.
5. Vanek J, Mayer O, Wohlfahrt P, Kielbergerova L, Krajcoviechova A, Bruthans J et al. The changes of secondary prevention practice in Czech post‑stroke patients between 2007 and 2012/13. Cor Et Vasa. 2016;58:E367-E73.
6. Vaněk J, Mayer O, Seidlerová J, Bruthans J, Kielbergerová L, Wohlfahrt P et al. A comparison of secondary prevention practice in poststroke and coronary heart disease patients. Public Health. 2016;137:64-72.
7. OECD. OECD (2019), „Mortality following ischaemic stroke“, in Health at a Glance 2019: OECD Indicators, OECD Publishing, Paris. StatLink https://doi.org/10.1787/888934016227.
8. Mayer O, Jr., Rosolová H, Sefrna F, Neumann M, Simon J. Analysis of mortality trends in the West Bohemian Region in comparison with the entire Czech Republic 1988-1995. Cas Lek Cesk. 1998;137:207-10.
9. ÚZIS. Regionální zpravodajství NZIS. Dostupné z https://reporting.uzis.cz/).
10. Mayer O, Jr., Seidlerová J, Bruthans J, Opatrný J, Hromádka M, Jirák J et al. The prognostic impact of renal function decline during hospitalization for myocardial infarction. J Comp Eff Res. 2021;10:219-28.
11. Cífková R, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M et al. 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post‑MONICA, 1985 - 2016/17. PLoS One. 2020;15:e0232845.
12. Rücker V, Heuschmann PU, O‘Flaherty M, Weingärtner M, Hess M, Sedlak C et al. Twenty‑Year Time Trends in Long‑Term Case‑Fatality and Recurrence Rates After Ischemic Stroke Stratified by Etiology. Stroke. 2020;51:2778-85.
13. Schmidt M, Jacobsen JB, Johnsen SP, Bøtker HE, Sørensen HT. Eighteen‑year trends in stroke mortality and the prognostic influence of comorbidity. Neurology. 2014;82:340-50.
14. Chaudhary D, Khan A, Shahjouei S, Gupta M, Lambert C, Avula V, et al. Trends in ischemic stroke outcomes in a rural population in the United States. J Neurol Sci. 2021;422:117339.
15. Bruthans J, Mayer O, Jarkovsky J, Zvolsky M. Long‑ term trends in the incidence, treatment, hospital fatality and subsequent mortality from acute myocardial infarction in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165:283-90.
16. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM et al. Endovascular thrombectomy after large‑vessel ischaemic stroke: a meta‑analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723-31.
17. Tawil SE, Cheripelli B, Huang X, Moreton F, Kalladka D, MacDougal NJ et al. How many stroke patients might be eligible for mechanical thrombectomy? Eur Stroke J. 2016;1:264-71.
18. McMeekin P, White P, James MA, Price CI, Flynn D, Ford GA. Estimating the number of UK stroke patients eligible for endovascular thrombectomy. Eur Stroke J. 2017;2:319-26.
19. Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6:I‑ lxii.
20. Neumann J, Šaňák D, Tomek A, Bar M, Herzig R, Kovář M et al. Doporučení pro intravenózní trombolýzu v léčbě akutního mozkového infarktu – verze 2021. Cesk Slov Neurol N 2021;84/117(3):291-99.
21. Šaňák D, Mikulík R, Tomek A, Bar M, Herzig R, Neumann J et al. Doporučení pro mechanickou trombektomii akutního mozkového infarktu – verze 2019. Cesk Slov Neurol N. 2019;82(6):700-5.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
![Issue E-3](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/1f7e4297f6025ac1036632d34e048b2c.jpg)
2022 Issue E-3
Most read in this issue
- Adrenal incidentaloma
- Acute infections in kidney transplant recipients
- Detection, examination and therapy of sexual dysfunctions in patients with diabetes
- The mortality risk of patients hospitalized for ischemic stroke between 2003 and 2019